Your session is about to expire
← Back to Search
Intervention Group 1 for Prostate Cancer
N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up [4 months]
Awards & highlights
Study Summary
This trial looks at how urologists diagnose and treat common urological conditions.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ [4 months]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~[4 months]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CPV-measured change in treatment Quality
CPV-measured differences in cost of care between control and intervention arms
CPV-measured rate of adoption for MyProstateScore
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group 2Experimental Treatment1 Intervention
Intervention Group 2 will receive information regarding the LynxDx test and will be given the test results if selected in Round 2 of CPV administration.
Group II: Intervention Group 1Experimental Treatment1 Intervention
Intervention Group 1 will receive information regarding the LynxDx rest and will be given the test results, whether selected or not, in Round 2 of CPV administration.
Group III: Control GroupActive Control1 Intervention
Control group treats their simulated patients using standard practice and have no introduction to the new LynxDx test.
Find a Location
Who is running the clinical trial?
Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,721 Total Patients Enrolled
2 Trials studying Prostate Cancer
359 Patients Enrolled for Prostate Cancer
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger